Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

[68Ga]Ga-ABY-025 PET in solid tumors Ended

2022-500448-39-00 Gastro-esophageal cancer with HER2-expression (cohort 1 4 2022-11-20
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis from Gastrointestinal cancer: a phase I study. Ended

2023-509135-17-00 Patients with advanced, irresectable peritoneal metasta 3 2022-11-18
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination with Cevostamab in Patients with Relapsed/Refract… Ended

2023-505212-38-00 Relapsed/Refractory Multiple Myeloma 3 2022-11-16
SC versus IV isatuximab in combination with pomalidomide and dexamethasone in RRMM Ended

2023-508869-32-00 Cancer - Plasma cell myeloma recurrent 5 2022-11-10
Clinical Study of Fianlimab in Combination With Cemiplimab versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated U… Ended

2023-505772-30-00 Melanoma 5 2022-11-09
A trial to determine the safety and effectiveness of CC-92480 in combination with bortezomib and dexamethasone as compared to pomalidomide i… Ended

2023-509859-13-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2022-11-09
Study of pembrolizumab, lenvatinib and chemotherapy combination in first line lung cancer Ended

2024-511412-25-00 First line treatment for extensive-stage small cell lun 4 2022-11-07
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
A Phase III Open-Label Trial of Acalabrutinib Plus Venetoclax versus Venetoclax plus Obinutuzumab in Previously Untreated Chronic Lymphocyti… Ended

2023-505866-27-00 Chronic Lymphocytic Leukemia or Small Lymphocytic Lymph 5 2022-10-28
A Study to Evaluate the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen-Exposed Patients with Relapsed/Refractory Multi… Ended

2023-505865-94-00 Relapsed/Refractory Multiple Myeloma 9 2022-10-26
This is a study that will evaluate the safety and efficacy of TOOKAD® (padeliporfin) Vascular Targeted Photodynamic Therapy (VTP) in the Tre… Ended

2024-512322-28-00 Low Grade Upper Tract Urothelial Cancer 5 2022-10-25
A Phase 3 study of Tafasitamab plus Lenalidomide in patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Ended

2023-505579-53-00 Diffuse large B-cell lymphoma (DLBCL) 5 2022-10-25
Phase 1b Study of Dato-DXd in Combination with Immunotherapy with or without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cance… Ended

2023-505992-54-00 Advanced or Metastatic Non-small Cell Lung Cancer (NSCL 3 2022-10-21
A clinical study to determine the dose and assess safety and efficacy of radioimmuntherapy in patients with glioblastoma, where Lutetium 177… Ended

2024-513638-39-00 Surgically treated high grade glioma after concomitant 1 2022-10-17
A Phase 2 Study of Isatuximab in combination with Pomalidomide and Dexamethasone in MM Patients who received one prior line of therapy conta… Ended

2024-516060-28-00 Multiple myeloma patients who received one prior line o 4 2022-10-17
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combin… Ended

2023-503467-41-00 Relapsed or Refractory Multiple Myeloma 5 2022-10-12
TACE-3: A two-arm multi-stage (TAMS) seamless phase II/III randomised trial of nivolumab in combination with TACE/TAE for patients with inte… Ended

2024-513882-38-00 Intermediate stage Hepatocellular carcinoma 10 2022-10-12
Reduction of hormone therapy duration in women with hormonesensitive breast cancer at very low risk of metastatic recurrence Ended

2024-514480-26-00 Post-menopausal women with localized luminal A breast c 4 2022-10-12
I-DXd in Patients With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Ended

2024-512368-79-00 Pretreated Extensive-stage Small Cell Lung Cancer (ES-S 4 2022-10-10
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-… Ended

2023-506871-88-00 Relapsed/Refractory Multiple Myeloma 3 2022-10-07
A FIRST-IN-HUMAN (FIH) STUDY OF IDRX-42 IN PARTICIPANTS WITH METASTATIC AND/OR UNRESECTABLE GASTROINTESTINAL STROMAL TUMORS (GIST) Ended

2024-514930-19-00 metastatic and/or unresectable gastrointestinal stromal 9 2022-10-07
METIMMOX-2: Oxaliplatin Chemotherapy and Immunotherapy to Patients with the Common pMMR/MSS Type of Large Bowel Cancer Spread to Other Organ… Ended

2022-500027-76-00 Colorectal cancer 4 2022-10-05
Study of ceralasertib plus durvalumab versus docetaxel for patients with advanced or metastatic non-small cell lung cancer Ended

2023-509429-37-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5 2022-10-03
A Phase 3 Study of Rusfertide (PTG-300) in Patients with Polycythemia Vera Ended

2023-509750-58-00 Polycythemia Vera 5 2022-09-21